BNTC logo

Benitec Biopharma Inc.

BNTC
Healthcare|Biotechnology|US
$9.54
+0.90 (+10.42%)
DCF Value
$2.63
Tangible Book / Share
$3.80
Cash / Share
$3.87
Next Earnings Report
Nov 13, 2026
EPS est. -$0.27
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Sep 14, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (1)

Nov 2030
Est. completion
P1P2Oculopharyngeal Muscular Dystrophy
A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia
NCT06185673n=30

Recent Press Releases

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301
Oct 28, 2026 · GlobeNewsWire
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
Oct 5, 2026 · GlobeNewsWire
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
Sep 14, 2026 · GlobeNewsWire

SEC Filings (76)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 28, 20268-KMaterial eventDocumentIndex
Oct 20, 2026DEFA14AProxy / shareholder voteDocumentIndex
Oct 20, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 5, 20268-KMaterial eventDocumentIndex
Sep 30, 20268-KMaterial eventDocumentIndex
Sep 24, 20268-KMaterial eventDocumentIndex
Sep 21, 2026EFFECTDocumentIndex
Sep 14, 2026S-3Shelf registrationDocumentIndex
Sep 14, 202610-KAnnual reportDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
May 29, 20268-KMaterial eventDocumentIndex
May 14, 202610-QQuarterly reportDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
Mar 20, 202610-K/AAnnual reportDocumentIndex
Feb 12, 20268-KMaterial eventDocumentIndex
Feb 12, 202610-QQuarterly reportDocumentIndex
Feb 11, 2026424B3Offering prospectusDocumentIndex
Feb 10, 2026EFFECTDocumentIndex
Jan 30, 2026S-3Shelf registrationDocumentIndex
Jan 29, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 8, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Dec 3, 2025SC 13GPassive 5%+ stakeDocumentIndex
Dec 2, 20258-KMaterial eventDocumentIndex
Nov 14, 20258-KMaterial eventDocumentIndex
Nov 14, 202510-QQuarterly reportDocumentIndex
Nov 12, 2025DEFA14AProxy / shareholder voteDocumentIndex
Nov 10, 2025SC 13D/AActivist / 5%+ stakeDocumentIndex
Nov 7, 20258-KMaterial eventDocumentIndex
Nov 7, 2025424B5Offering prospectusDocumentIndex
Nov 5, 2025424B5Offering prospectusDocumentIndex
Nov 4, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 3, 20258-KMaterial eventDocumentIndex
Oct 14, 2025DEFA14AProxy / shareholder voteDocumentIndex
Oct 14, 2025DEF 14AProxy / shareholder voteDocumentIndex
Sep 29, 2025EFFECTDocumentIndex
Sep 22, 2025S-3Shelf registrationDocumentIndex
Sep 22, 20258-KMaterial eventDocumentIndex
Sep 22, 202510-KAnnual reportDocumentIndex
Sep 12, 20258-KMaterial eventDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex